Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-077655
Filing Date
2025-08-13
Accepted
2025-08-13 17:17:58
Documents
18

Document Format Files

Seq Description Document Type Size
1 S-3 tm2522572-1_s3.htm S-3 514501
2 EXHIBIT 1.2 tm2522572d2_ex1-2.htm EX-1.2 198235
3 EXHIBIT 4.3 tm2522572d2_ex4-3.htm EX-4.3 444864
4 EXHIBIT 5.1 tm2522572d2_ex5-1.htm EX-5.1 29016
5 EXHIBIT 23.2 tm2522572d2_ex23-2.htm EX-23.2 2398
6 FILING FEE IXBRL tm2522572d2_ex-filingfees.htm   iXBRL EX-FILING FEES 52611
7 GRAPHIC tm2522572d2_ex5-1img001.jpg GRAPHIC 13473
8 GRAPHIC lg_immuneering-4clr.jpg GRAPHIC 10109
  Complete submission text file 0001104659-25-077655.txt   1452594

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2522572d2_ex-filingfees_htm.xml XML 18949
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289589 | Film No.: 251212946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)